Potomac Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $1.03M | Hold |
11,554
| – | – | 1.2% | 22 |
|
|
2023
Q3 | $844K | Hold |
11,554
| – | – | 1.08% | 23 |
|
|
2023
Q2 | $961K | Sell |
11,554
-846
| -7% | -$70.4K | 0.99% | 25 |
|
|
2023
Q1 | $945K | Hold |
12,400
| – | – | 0.99% | 28 |
|
|
2022
Q4 | $1.03M | Buy |
12,400
+1,900
| +18% | +$158K | 1.2% | 20 |
|
|
2022
Q3 | $833K | Sell |
10,500
-700
| -6% | -$55.5K | 0.95% | 28 |
|
|
2022
Q2 | $832K | Buy |
+11,200
| New | +$832K | 0.96% | 33 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 75 |
|